Evidence map›Paper›PMID 41931169›Full record

ArticleHuman cell2026

Ubiquitously expressed prefoldin-like chaperone (UXT) regulates putrescine metabolism and promotes colorectal cancer progression.

Ming Chen, Shisi Huang, Lu Gong, Xingcheng Wu, Ying Li, Hanbing Wu

Abstract read
PubMed Publisher
In one paragraph

Article in Human cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ming Chen *Department of Gastroenterology, Hunan University of Medicine General Hospital, Huaihua, 418000, Hunan, People's Republic of China.
Shisi Huang *Department of Medical Healthcare, Central South University Xiangya School of Medicine Affiliated Haikou Hospital, Haikou, 570208, Hainan, People's Republic of China.
Lu GongDepartment of Clinical Pharmacy, Hunan University of Medicine General Hospital, Huaihua, 418000, Hunan, People's Republic of China.
Xingcheng WuIntensive Medicine, Hunan University of Medicine General Hospital, Huaihua, 418000, Hunan, People's Republic of China.
Ying LiDepartment of Oncology, School of Medicine, Jishou University, Jishou, 416000, Hunan, People's Republic of China.
Hanbing WuDepartment of Oncology, Hunan University of Medicine General Hospital, Huaihua, 418000, Hunan, People's Republic of China. wuhanbing_cm@sina.cn.

Funding

Natural Science Foundation of Hunan Province 2024JJ7348Natural Science Foundation of Hunan Province 2025JJ70426
6 · The paper itself

Abstract

Colorectal cancer (CRC) is a prevalent and increasingly common malignancy that poses significant threats to patient survival and quality of life. This study investigates the role of ubiquitously expressed prefoldin-like chaperone (UXT) in regulating polyamine metabolism, particularly putrescine, and its impact on CRC progression. Through comprehensive bioinformatics analysis, UXT was identified as a key factor positively correlated with putrescine abundance in CRC cell lines. Clinical samples confirmed upregulation of UXT and its positive correlation with putrescine levels. Functional assays revealed that UXT knockdown reduced cell viability, migration, and invasion, while overexpression enhanced these phenotypes. Additionally, UXT knockdown decreased putrescine levels and increased the expression of ornithine decarboxylase antizymes (OAZ1, OAZ2, OAZ3), which negatively regulate polyamine synthesis. Conversely, UXT overexpression exhibited the opposite effects. In vivo experiments using a subcutaneous xenograft tumor model in nude mice showed that UXT overexpression enhanced tumor growth and putrescine levels, and UXT overexpression is associated with an increase in M2 macrophage markers, along with reduced M1-associated markers, while UXT knockdown inhibited these effects. These findings suggest that UXT contributes to CRC progression by regulating polyamine metabolism and macrophage polarization, demonstrating its potential as a therapeutic target to disrupt metabolic pathways essential for cancer cell survival and proliferation.

Indexed as

Colorectal NeoplasmsGene ExpressionMolecular ChaperonesPutrescineAnimalsCell Line, TumorCell MovementCell SurvivalDisease ProgressionHumansMacrophagesMice, NudePolyaminesProteinsMolecular Chaperonesornithine decarboxylase antizymePolyaminesProteinsPutrescineCell proliferationColorectal cancerPolyamine metabolismPutrescineTumor growthUbiquitously expressed prefoldin-like chaperone (UXT)

Identifiers

PMID41931169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.